4.7 Review

Sensing the outside world: TSLP regulates barrier immunity

Journal

NATURE IMMUNOLOGY
Volume 11, Issue 4, Pages 289-293

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1852

Keywords

-

Categories

Funding

  1. National Institutes of Health [AI068731, AI044259, AR055695, AR56113, AI061570, AI074878, AI083480]
  2. Burroughs Wellcome Fund
  3. Crohn's and Colitis Foundation of America
  4. University of Pennsylvania
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061570, R21AI083480, R01AI074878, R01AI068731, R01AI044259] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055695, R01AR056113] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Thymic stromal lymphopoietin (TSLP) is an interleukin 7 (IL-7)-like cytokine originally characterized by its ability to promote the activation of B cells and dendritic cells (DCs). Subsequent studies have shown that TSLP promotes T helper type 2 (T(H)2) cell responses associated with immunity to some helminth parasites and the pathogenesis of many inflammatory diseases, including atopic dermatitis and asthma. This review will focus on recent findings indicating that in addition to influencing B cell and DC function, TSLP can promote T(H)2 cytokine-associated inflammation by directly promoting the effector functions of CD4(+) T(H)2 cells, basophils and other granulocyte populations while simultaneously limiting the expression of DC-derived proinflammatory cytokines and promoting regulatory T cell responses in peripheral tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available